health-related quality of life and health utility values in beta thalassemia major patients receiving different types of iron chelators in iran

نویسندگان

meysam seyedifar pharmaceutical management and economics research center, tehran university of medical sciences, tehran, iran

farid abedin dorkoosh department of pharmacoeconomics and pharmaceutical administration, faculty of pharmacy, tehran university of medical sciences, tehran, iran

amir ali hamidieh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

majid naderi department of pediatrics hematology-oncology, ali-ebne abitaleb hospital research center for children and adolescent health [rccah], zahedan university of medical sciences, zahedan, iran

چکیده

background: thalassemia is a chronic, inherited blood disorder, which in its most severe form, causes life-threatening anemia. thalassemia patients not only engage with difficulties of blood transfusion and iron chelating therapy but also have some social challenges and health threatening factors. there are some reports on quality of life in thalassemia patients around the world from southeast of asia to italy in europe and united states. in this study, we tried to evaluate and compare health related quality of life (hrqol) and the health utility in beta thalassemia major patients receiving different types of iron chelators and living in different socio-economical situations. subjects and methods: eq-5d-3l accompanied by a visual analogue scale (vas) questionnaire was used. the respondents were patients with beta thalassemia major that were at least 12 years old selected from 3 provinces of sistan-blouchestan, fars and mazandaran. comorbidities including heart complication, diabetes mellitus and hepatitis and also types of iron chelators (oral, injection, combination of both) were also asked. cross tab and anova analysis conducted to evaluate each dimension score and health utility differences between provinces, iron chelation methods, comorbidities, age group and gender. results: 528 patients answered the questionnaires. the health utility of patients that received oral iron chelator were 0.87 ± .01 for oral iron chelators versus 0.81 ± .01 for injection dosage form (p<0.05). increase in age was accompanied by decrease in health utility. females faced more usual activity problems, anxiety and depression. heart problems were more prevalent in males. conclusion: this study suggests that the quality of life of beta thalassemia major patients is dependent on type of iron chelation treatment which they received, the gender they have, the comorbidities they suffer and socio-economical situations they live in. .

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in Iran

Background: Thalassemia is a chronic, inherited blood disorder, which in its most severe form, causes life-threatening anemia. Thalassemia patients not only engage with difficulties of blood transfusion and iron chelating therapy but also have some social challenges and health threatening factors. There are some reports on quality of life in thalassemia patients around the world from southeast ...

متن کامل

Quality of Life and Some Related Factors in Patients With Beta Thalassemia Major in Southwest Iran

Background: Thalassemia is one of the most common genetic disorders in the world, especially in Iran. The study of various aspects affecting the physical and mental health of patients with beta thalassemia major has become more important. The aim of this study was to evaluate the Quality of life and some related factors in patients with beta-thalassemia major in Southwest Iran. Methods: In thi...

متن کامل

Health-Related Quality of Life in β Thalassemia Major Children in North of Iran

Background: Advances in treatment of thalassemia major have improved the life expectancy of the patients and therefore their quality of life as other chronic diseases. This study was conducted to assess health- related quality of life in these patients in Guilan province. Methods: In a cross-sectional study, thirty-one children, aged 8-12 years, with &beta;-thalassemia major were interviewed i...

متن کامل

Assessment of oral health and quality of life in hemophilia and thalassemia major patients

Background and Aims: The chronic blood disorders could have negative effects on various fields of patient’s quality of life. The aim of this study was to evaluate the relationship between the quality of life and oral health in major thalassemia and hemophilia patients. Materials and Methods: This cross- sectional study was performed in 1398 on 56 hemophilia patients and 35 thalassemia major pa...

متن کامل

Quality of Life in Patients Suffering from Beta-Thalassemia Major in Amirkola, Iran

Abstract Introduction: Thalassemia is regarded as a genetic hematologic disease that affects various aspects of patients’ life. Measuring the health-related quality of life is a multidimensional concept that focuses on the disease as well as its treatment. Materials and methods:  This  cross-sectional study consisted of  50 adolescents aged 12-18 years suffering from Thalassemia major, ou...

متن کامل

associates of poor physical and mental health-related quality of life in beta thalassemia-major/intermedia

background : using two logistic regression models, we determined the associates of poor physical and mental health related quality of life (hrqol) among beta thalassemia patients. methods : in this cross-sectional study which was conducted during 2006 and 2007 in outpatient adult thalassemia clinic, blood transfusion organization, tehran, iran, short form 36 (sf-36) was used for measuring hrqol...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
international journal of hematology-oncology and stem cell research

جلد ۱۰، شماره ۴، صفحات ۲۲۴-۲۳۱

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023